# Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combined-immunosuppression-and-radiotherapy-in-thyroid-eye-disease-cirted-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rathie Rajendram,Peter Taylor,Victoria Wilson,Nicola Harris,Olivia Morris,Marjorie Tomlinson,Sue Yarrow,Helen Garrott,H. Herbert,Andrew D. Dick,Anne Cook,Rao Gattamaneni,Rajni Jain,Jane M. Olver,Steven J. Hurel,Fion Bremner,Suzannah R. Drummond,Ewan Kemp,Diana Ritchie,Nichola Rumsey,Daniel S. Morris,Carol Lane,Nachi Palaniappan,Chunhei Li,Julie Pell,Robert K. Hills,Daniel G. Ezra,Mike J. Potts,Sue Jackson,Geoffrey E. Rose,Nicholas Plowman,Catey Bunce,Jimmy Uddin,Richard Lee,Colin Dayan |
| Citations | 105 |
| DOI | 10.1016/s2213-8587(18)30021-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://research-information.bris.ac.uk/files/163723473/Main_Manuscript_CIRTED_FINALPNT_1_.pdf |
| OpenAlex ID | https://openalex.org/W2786016821 |
| PMID | 29396245 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Daniel G. Ezra](https://scholariq.org/researchers/daniel-g-ezra/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Ophthalmology and Eye Disorders](https://scholariq.org/topics/ophthalmology-and-eye-disorders/)

## Paper topics

- [Ophthalmology and Eye Disorders](https://scholariq.org/topics/ophthalmology-and-eye-disorders/)
- [Ocular Oncology and Treatments](https://scholariq.org/topics/ocular-oncology-and-treatments/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.